RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGNPF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Algernon Pharmaceuticals Inc. stock downgraded after the last trading session.
(Updated on May 01, 2024)

Buy or Hold candidate since Apr 23, 2024 Loss -7.48% PDF

No changes to the price of Algernon Pharmaceuticals Inc. stock on the last trading day (Wednesday, 1st May 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0823 to a day high of $0.0823. The price has risen in 4 of the last 10 days and is up by 22.62% over the past 2 weeks.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 36.16% during the next 3 months and, with a 90% probability hold a price between $0.0908 and $0.131 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AGNPF Signals & Forecast

The Algernon Pharmaceuticals Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.0862. On a fall, the stock will find some support from the long-term average at approximately $0.0749. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Monday, April 29, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Algernon Pharmaceuticals Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0764 and $0.0710. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Algernon Pharmaceuticals Inc. finds support just below today's level at $0.0764. If this is broken, then the next support from accumulated volume will be at $0.0710 and $0.0630.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 11.36%

Our recommended stop-loss: $0.0777 (-5.60%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (AGNPF) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Algernon Pharmaceuticals Inc. to open at $0.0823, and during the day (based on 14 day Average True Range), to move between $0.0748 and $0.0899, which gives a possible trading interval of +/-$0.0076 (+/-9.21%) up or down from last closing price. If Algernon Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 18.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0831 (0.92%) than the support at $0.0764 (7.21%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Algernon Pharmaceuticals Inc. stock A Buy?

Algernon Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Algernon Pharmaceuticals Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$0.0823 ( 0%) $0.0823

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AGNPF

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0823 .
R2 0.0823 .
R1 0.0823 .
Current price: 0.0823
Support S1 0.0823 .
S2 0.0823 .
S3 0.0823 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0914 11.05 %
R2 0.0890 8.09 %
R1 0.0831 0.92 %
Current price 0.0823
Support S1 0.0764 -7.21%
S2 0.0710 -13.77%
S3 0.0630 -23.49%

FAQ

What is the symbol for Algernon Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Algernon Pharmaceuticals Inc. is AGNPF and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Algernon Pharmaceuticals Inc. Stock?
Algernon Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Algernon Pharmaceuticals Inc. Stock?
Algernon Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Algernon Pharmaceuticals Inc. Stock.

What's the current price of Algernon Pharmaceuticals Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Algernon Pharmaceuticals Inc. (AGNPF) share was $0.0823.

What is the 52-week high and low for Algernon Pharmaceuticals Inc. Stock?
The 52-week high for Algernon Pharmaceuticals Inc. Stock is $0.203 and the 52-week low is $0.0353.

What is the market capitalization of Algernon Pharmaceuticals Inc. Stock?
As of the May 01, 2024, the market capitalization of Algernon Pharmaceuticals Inc. is 1.648M.

When is the next earnings date for Algernon Pharmaceuticals Inc.?
The upcoming earnings date for Algernon Pharmaceuticals Inc. is May 24, 2024.
Click to get the best stock tips daily for free!

About Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals. Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets N... AGNPF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT